ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05200	Pathways in cancer	36/136	492/7206	5.48246784554e-13
ko05205	Proteoglycans in cancer	24/136	271/7206	1.59589781229e-10
ko05217	Basal cell carcinoma	12/136	68/7206	3.70704670181e-09
ko04390	Hippo signaling pathway	18/136	188/7206	1.1519681832e-08
ko05224	Breast cancer	15/136	174/7206	8.21983043664e-07
ko04360	Axon guidance	17/136	233/7206	1.54367540588e-06
ko04512	ECM-receptor interaction	10/136	79/7206	1.95879001047e-06
ko04510	Focal adhesion	17/136	240/7206	2.32376606668e-06
ko04550	Signaling pathways regulating pluripotency of stem cells	14/136	165/7206	2.36639484829e-06
ko04916	Melanogenesis	13/136	142/7206	2.36730921537e-06
ko05206	MicroRNAs in cancer	14/136	177/7206	5.42408140163e-06
ko05146	Amoebiasis	10/136	99/7206	1.53762106433e-05
ko04974	Protein digestion and absorption	9/136	96/7206	7.52645156166e-05
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	8/136	79/7206	0.000110682123589
ko04151	PI3K-Akt signaling pathway	19/136	390/7206	0.000120076738415
ko04310	Wnt signaling pathway	12/136	181/7206	0.000147285784618
ko05222	Small cell lung cancer	8/136	89/7206	0.000255811239334
ko05219	Bladder cancer	6/136	48/7206	0.000258890900104
ko04668	TNF signaling pathway	8/136	120/7206	0.00186694113153
ko01522	Endocrine resistance	8/136	124/7206	0.0022969480714
ko04350	TGF-beta signaling pathway	7/136	103/7206	0.00321424946172
ko04520	Adherens junction	7/136	103/7206	0.00321424946172
ko04810	Regulation of actin cytoskeleton	12/136	264/7206	0.00406028489386
ko05215	Prostate cancer	7/136	111/7206	0.00486621629292
ko04670	Leukocyte transendothelial migration	8/136	151/7206	0.00758469867265
ko05166	HTLV-I infection	12/136	292/7206	0.0123257269821
ko04933	AGE-RAGE signaling pathway in diabetic complications	7/136	135/7206	0.0136843053853
ko01521	EGFR tyrosine kinase inhibitor resistance	6/136	106/7206	0.0148019580645
ko04012	ErbB signaling pathway	6/136	109/7206	0.0167892296073
ko05212	Pancreatic cancer	5/136	83/7206	0.0199654411213
ko04320	Dorso-ventral axis formation	3/136	31/7206	0.0201001705226
ko04392	Hippo signaling pathway -multiple species	3/136	31/7206	0.0201001705226
ko04015	Rap1 signaling pathway	11/136	278/7206	0.0202215712122
ko05220	Chronic myeloid leukemia	5/136	85/7206	0.0218977046654
ko04150	mTOR signaling pathway	8/136	184/7206	0.0228116528474
ko04918	Thyroid hormone synthesis	5/136	86/7206	0.0229079344871
ko04912	GnRH signaling pathway	6/136	122/7206	0.0275304949431
ko04060	Cytokine-cytokine receptor interaction	8/136	191/7206	0.0277453372765
ko04330	Notch signaling pathway	4/136	62/7206	0.0291556542214
ko05145	Toxoplasmosis	6/136	126/7206	0.0315815149557
ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	2/136	15/7206	0.0316166265848
ko04640	Hematopoietic cell lineage	4/136	64/7206	0.03227334796
ko04341	Hedgehog signaling pathway - fly	3/136	38/7206	0.0343062354194
ko04658	Th1 and Th2 cell differentiation	5/136	96/7206	0.034689880467
ko04915	Estrogen signaling pathway	6/136	131/7206	0.0371693897403
ko04144	Endocytosis	12/136	342/7206	0.0376342837147
ko05100	Bacterial invasion of epithelial cells	5/136	99/7206	0.0388394720574
ko05410	Hypertrophic cardiomyopathy (HCM)	5/136	100/7206	0.040287312648
ko04931	Insulin resistance	6/136	137/7206	0.044666856494
ko05161	Hepatitis B	7/136	173/7206	0.044919590577
ko04925	Aldosterone synthesis and secretion	5/136	105/7206	0.0480162302914
ko04218	Cellular senescence	7/136	177/7206	0.0497372807323